These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 12948311

  • 1. Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery.
    Scuderi B, Driussi GB, Chizzolini M, Salvetat ML, Beltrame G.
    Eur J Ophthalmol; 2003 Jul; 13(6):536-40. PubMed ID: 12948311
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP, De Castro LE, Vroman DT, Solomon KD.
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery.
    Bodaghi B, Weber ME, Arnoux YV, Jaulerry SD, Le Hoang P, Colin J.
    Eur J Ophthalmol; 2005 Aug; 15(6):702-11. PubMed ID: 16329054
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM, Amon M, Findl O, Kahraman G, Barisani-Asenbauer T.
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [Abstract] [Full Text] [Related]

  • 5. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C, Neubauer AS, Kampik A, Schönfeld CL.
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
    [Abstract] [Full Text] [Related]

  • 6. Topical nonsteroidal anti-inflammatory drugs in uncomplicated cataract surgery: effect of sodium naproxen.
    Russo P, Papa V, Russo S, Di Bella A, Pabst G, Milazzo G, Balestrazzi A, Caporossi A, Naproxen Study Group.
    Eur J Ophthalmol; 2005 Aug; 15(5):598-606. PubMed ID: 16167290
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP, Solomon KD, Sandoval HP, Vroman DT.
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation.
    Diestelhorst M, Schmidl B, Konen W, Mester U, Raj PS.
    J Cataract Refract Surg; 1996 Jan; 22 Suppl 1():788-93. PubMed ID: 9279673
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution for inflammation after cataract surgery: a randomized, comparative, active treatment-controlled trial.
    Barraquer RI, Alvarez de Toledo JP, Montané D, Escoto RM, Garcia Torres C, Bennani-Tazzi M.
    Eur J Ophthalmol; 1998 Jan; 8(3):173-8. PubMed ID: 9793772
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery.
    Baiza-Duran LM, Quintana-Hau J, Tornero-Montaño R, Ortiz MI, Castañeda-Hernández G, Alanis-Villarreal L, Avalos-Urzua G, Bustos-Zermeño R, Domene-Hinojosa JL, Gómez-Bastar P, Ibañez-Hernandez MA, Morales-Gómez ME, Velasco-Gallegos G, Villar-Kuri J.
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):89-95. PubMed ID: 19203564
    [Abstract] [Full Text] [Related]

  • 16. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.
    Asano S, Miyake K, Ota I, Sugita G, Kimura W, Sakka Y, Yabe N.
    J Cataract Refract Surg; 2008 Jan; 34(1):57-63. PubMed ID: 18165082
    [Abstract] [Full Text] [Related]

  • 17. Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.
    Rho DS.
    J Cataract Refract Surg; 2003 Dec; 29(12):2378-84. PubMed ID: 14709300
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the anti-inflammatory effects of diclofenac and flurbiprofen eye drops after cataract extraction.
    Koçak I, Yalvaç IS, Koçak A, Nurözler A, Unlü N, Kasim R, Duman S.
    Acta Ophthalmol Scand; 1998 Jun; 76(3):343-5. PubMed ID: 9686850
    [Abstract] [Full Text] [Related]

  • 20. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study.
    Solomon KD, Vroman DT, Barker D, Gehlken J.
    J Cataract Refract Surg; 2001 Aug; 27(8):1232-7. PubMed ID: 11524195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.